BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16401063)

  • 1. Humoral immune responses to testis antigens in sera from patients with prostate cancer.
    Hoeppner LH; Dubovsky JA; Dunphy EJ; McNeel DG
    Cancer Immun; 2006 Jan; 6():1. PubMed ID: 16401063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
    Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomic analysis of human sarcoma.
    Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
    Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
    Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.
    Dubovsky JA; Albertini MR; McNeel DG
    J Immunother; 2007 Oct; 30(7):675-83. PubMed ID: 17893560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
    Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
    Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard treatments induce antigen-specific immune responses in prostate cancer.
    Nesslinger NJ; Sahota RA; Stone B; Johnson K; Chima N; King C; Rasmussen D; Bishop D; Rennie PS; Gleave M; Blood P; Pai H; Ludgate C; Nelson BH
    Clin Cancer Res; 2007 Mar; 13(5):1493-502. PubMed ID: 17332294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.
    Dubovsky JA; McNeel DG
    Prostate; 2007 Dec; 67(16):1781-90. PubMed ID: 17929270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
    Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NY-ESO-1 protein expression and humoral immune responses in prostate cancer.
    Fosså A; Berner A; Fosså SD; Hernes E; Gaudernack G; Smeland EB
    Prostate; 2004 Jun; 59(4):440-7. PubMed ID: 15065093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.
    Siliņa K; Zayakin P; Kalniņa Z; Ivanova L; Meistere I; Endzeliņš E; Abols A; Stengrēvics A; Leja M; Ducena K; Kozirovskis V; Linē A
    J Immunother; 2011 Jan; 34(1):28-44. PubMed ID: 21150711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
    Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
    Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
    Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
    Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.
    Almeida LG; Sakabe NJ; deOliveira AR; Silva MC; Mundstein AS; Cohen T; Chen YT; Chua R; Gurung S; Gnjatic S; Jungbluth AA; Caballero OL; Bairoch A; Kiesler E; White SL; Simpson AJ; Old LJ; Camargo AA; Vasconcelos AT
    Nucleic Acids Res; 2009 Jan; 37(Database issue):D816-9. PubMed ID: 18838390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer/testis (CT) antigens: potential targets for immunotherapy.
    Caballero OL; Chen YT
    Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigens recognized by autologous antibodies of patients with soft tissue sarcoma.
    Segal NH; Blachere NE; Shiu HY; Leejee S; Antonescu CR; Lewis JJ; Wolchok JD; Houghton AN
    Cancer Immun; 2005 Mar; 5():4. PubMed ID: 15745419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
    Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
    Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.